CD274 and hypothyroidism: A meta-analysis on ICIs[16] demonstrated that adjuvant therapy with PD-1/PD-L1 inhibitors may significantly reduce the risk of recurrence Another study[17] investigating AEs associated with ICIs revealed that immunotherapy may confer greater clinical benefits in female patients, who concurrently demonstrate a higher incidence of hypothyroidism.